4 Recruiting Studies Using Rp2
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Rp2
🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
📍 Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania
Gastric Adenocarcinoma
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
📍 HonorHealth Research Insisute — Scottsdale, Arizona
Metastatic Uveal Melanoma
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
📍 Beverly Hills Cancer Center — Beverly Hills, California
Hepatocellular Carcinoma
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
📍 Brigham and Women's Hospital — Boston, Massachusetts
High-Risk Oral Precancerous Disease
View Study & Checklist ➔